WallStreetZenWallStreetZen

NASDAQ: LGVN
Longeveron Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their LGVN stock forecasts and price targets.

Forecast return on equity

Is LGVN forecast to generate an efficient return?

Company
-360.26%
Industry
16.87%
Market
150.38%
LGVN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is LGVN forecast to generate an efficient return on assets?

Company
-230.79%
Industry
-4.49%
LGVN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

LGVN earnings per share forecast

What is LGVN's earnings per share in the next 2 years based on estimates from 5 analysts?

Avg 1 year Forecast
-$1.34
Avg 2 year Forecast
-$1.68

LGVN revenue forecast

What is LGVN's revenue in the next 2 years based on estimates from 5 analysts?

Avg 1 year Forecast
$709.2k-50.64%
Avg 2 year Forecast
$11.2M+682.39%
LGVN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

LGVN revenue growth forecast

How is LGVN forecast to perform vs Biotechnology companies and vs the US market?

Company
-50.64%
Industry
55.55%
Market
26.24%
LGVN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
LGVN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

LGVN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
LGVN$0.97N/AN/A
DARE$1.44$12.00+733.33%Buy
FBLG$0.31$5.50+1,662.82%Strong Buy
NRSN$0.86$8.50+889.52%Strong Buy
TVGN$5.38$100.00+1,758.74%Strong Buy
View Top Biotech Stocks

Longeveron Stock Forecast FAQ

What is LGVN's earnings growth forecast for 2026-2027?

(NASDAQ: LGVN) Longeveron's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 27.5%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,669.44%.

Longeveron's earnings in 2026 is -$21,341,000.On average, 5 Wall Street analysts forecast LGVN's earnings for 2026 to be -$28,613,793, with the lowest LGVN earnings forecast at -$34,495,269, and the highest LGVN earnings forecast at -$21,951,535.

In 2027, LGVN is forecast to generate -$35,903,239 in earnings, with the lowest earnings forecast at -$34,495,269 and the highest earnings forecast at -$36,959,216.

If you're new to stock investing, here's how to buy Longeveron stock.

What is LGVN's revenue growth forecast for 2026-2027?

(NASDAQ: LGVN) Longeveron's forecast annual revenue growth rate of -50.64% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 55.55%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 26.24%.

Longeveron's revenue in 2026 is $1,437,000.On average, 5 Wall Street analysts forecast LGVN's revenue for 2026 to be $15,130,069, with the lowest LGVN revenue forecast at $10,453,112, and the highest LGVN revenue forecast at $22,996,846.

In 2027, LGVN is forecast to generate $239,845,581 in revenue, with the lowest revenue forecast at $11,686,579 and the highest revenue forecast at $481,291,128.

What is LGVN's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: LGVN) forecast ROA is -230.79%, which is lower than the forecast US Biotechnology industry average of -4.49%.

What is LGVN's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: LGVN) Longeveron's current Earnings Per Share (EPS) is -$0.97. On average, analysts forecast that LGVN's EPS will be -$1.34 for 2026, with the lowest EPS forecast at -$1.62, and the highest EPS forecast at -$1.03. In 2027, LGVN's EPS is forecast to hit -$1.68 (min: -$1.62, max: -$1.73).

What is LGVN's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: LGVN) forecast ROE is -360.26%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.